Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis (Q36042432)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

author name string

Adrianos Nezos

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Fotini Gravani

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Anna Tassidou

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Efstathia K Kapsogeorgou

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Michael Voulgarelis

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Michael Koutsilieris

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Mary K Crow

7

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Clio P Mavragani

8

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

publication date

13 July 2015

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Journal of Autoimmunity

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

63

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

47-58

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Molecular Subsetting of Interferon Pathways in Sjögren's Syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

A phase I trial of bortezomib and interferon-α-2b in metastatic melanoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren's syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Interferon-γ and systemic autoimmunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Increased serum type I interferon activity in organ-specific autoimmune disorders: clinical, imaging, and serological associations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

The Interferon-Signature of Sjögren's Syndrome: How Unique Biomarkers Can Identify Underlying Inflammatory and Immunopathological Mechanisms of Specific Diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

The interferon signature in autoimmune diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Activation of the type I interferon pathway in primary Sjögren's syndrome: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Systems biology of interferon responses.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Activation of the type I interferon pathway in primary Sjogren’s syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Peripheral blood gene expression profiling in Sjögren's syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Interferon-gamma: a historical perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Systemic increase in type I interferon activity in Sjögren's syndrome: a putative role for plasmacytoid dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

IRAK-4-dependent degradation of IRAK-1 is a negative feedback signal for TLR-mediated NF-kappaB activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Interferon-alpha induces up-regulation and nuclear translocation of the Ro52 autoantigen as detected by a panel of novel Ro52-specific monoclonal antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

The risk of lymphoma development in autoimmune diseases: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Interferons alpha and gamma induce p53-dependent and p53-independent apoptosis, respectively

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Mechanisms of Interferon-alpha induced apoptosis in malignant cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Analysis of TH1 and TH2 cytokine production in low grade B cell gastric MALT-type lymphomas stimulated in vitro with Helicobacter pylori

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

Antimalarials in Sjögren's syndrome--the Greek experience.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

High frequency of t(14;18) translocation in salivary gland lymphomas from Sjögren's syndrome patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

2 October 2017

A BAFF receptor His159Tyr mutation in Sjögren's syndrome-related lymphoproliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

27 July 2018

A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

23 September 2018

Interferon-γ-producing B cells induce the formation of gastric lymphoid follicles after Helicobacter suis infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

23 September 2018

B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

23 September 2018

A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

23 September 2018

B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

23 September 2018

Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: Correlation with certain features of immune hyperactivity and factors associated

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

23 September 2018

DNA microarray analysis of labial salivary glands of patients with Sjogren's syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

23 September 2018

Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

23 September 2018

A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

23 September 2018

The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

23 September 2018

Molecular cross-talk between the TRAIL and interferon signaling pathways.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4564326

23 September 2018

Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/26183766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/26183766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/26183766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SS-A/Ro52 promotes apoptosis by regulating Bcl-2 production

1 reference

https://pubmed.ncbi.nlm.nih.gov/26183766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD4+ Th1-cells predominate in low-grade B-cell lymphoma of gastric mucosa-associated lymphoid tissue (MALT type)

1 reference

https://pubmed.ncbi.nlm.nih.gov/26183766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sjögren's syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/26183766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphoma development in Sjögren's syndrome: novel p53 mutations

1 reference

https://pubmed.ncbi.nlm.nih.gov/26183766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-gamma is increased in patients with primary Sjogren's syndrome and Raynaud's phenomenon

1 reference

https://pubmed.ncbi.nlm.nih.gov/26183766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sjögren syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/26183766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of Fas ligand-mediated apoptosis by interferon-alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/26183766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of type I interferon in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/26183766

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.JAUT.2015.07.002

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36042432&oldid=1648481769"